Companies related to Antibody-Drug Conjugates

Science revives

Where Empathy Meets Science to Accelerate Life Sciences Research

Putting science to work

BRINGING YOUR SCIENCE TO LIFE

Passion for Innovation. Compassion for Patients.

We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis

MANAGING CYANOBACTERIA

Passion for Innovation. Compassion for Patients.

Building tomorrow's antibody-drug conjugates (ADCs)

Your CDMO Partner for On-Time Process Development and cGMP Manufacturing.

Creating class-leading ADCs with enhanced tumor specificity

Biotech Consultancy Supporting Biopharmaceutical Development Globally

RABCancer: A Predictive Platform for Antibody-Drug Conjugates. Follow us for insights into ADC trafficking & biomarkers

Securing Life Sciences Supply Chain - Customized conjugation & formulation solutions. celares is now part of Biosynth.

Integrated Chemistry Solution Provider

We target the cells that drive fibrosis

Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer.

Making way for breakthroughs

Reimagining ADCs.